Log in to save to my catalogue

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of ven...

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of ven...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c77836ed356f4db6a5fa3d2f59504785

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia

About this item

Full title

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2023-10, Vol.14 (1), p.6724-6724, Article 6724

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Alternative Titles

Full title

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c77836ed356f4db6a5fa3d2f59504785

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c77836ed356f4db6a5fa3d2f59504785

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-023-42562-2

How to access this item